Dr Stephen Falk

MB, ChB, MRCP, FRCR, MD

Consultant Clinical Oncologist

Special clinical interest in lung; oesophageal; stomach and colorectal cancer.

Dr Falk’s major clinical interests are thoracic (lung) and gastro-intestinal malignancies (oesophagus, stomach, pancreas, colo-rectal).

He provides specialist chemotherapy and radiotherapy treatments, often in combination. A major interest in clinical research was stimulated as a MRC Clinical Scientist in Cambridge where the MRC cancer trials unit was situated at the time. He has an MD related to lung cancer and scheduling of topoisomerase poisons, with and without radiation, which is the basis of on-going interest in chemo-radiotherapy and new drugs.

Where possible all patients who are referred will be offered an appropriate clinical trial

NHS Hospital / current post(s)

Consultant Clinical Oncologist, Honorary Senior Lecturer Bristol Haematology and Oncology centre

Clinical interests

Treatment of Oeosophago-gastric, hepatobiliary, pancreatic and Colorectal Cancer